Update on trials of Celator Pharma's cancer candidate; Can turmeric treat Alzheimer's?;

> Celator Pharmaceuticals' stock rose on positive clinical trial results of its Phase II candidate for acute myeloid leukemia, which uses its CombiPlex delivery platform. Release

> Vanderbilt University is studying curcumin, found in the spice turmeric, as a treatment for Alzheimer's disease. "Curcumin has demonstrated ability to enter the brain, bind and destroy the beta-amyloid plaques present in Alzheimer's with reduced toxicity," said biomedical engineering professor Wellington Pham. Story

> University of Florida spinoff Prometheon Pharma is promoting its needle-free transdermal patch to external partners. The patch contains a formulation that melts into a gel upon contact with the skin, and can deliver drugs at a constant and consistent rate, according to the company. Release

> BioLight Life Sciences announced that it has invested in a new ophthalmic company which has the rights to novel drug delivery platform developed by Hebrew University in Israel. Release